Sabra Health Care REIT, Inc. - Common Stock (SBRA)
Financial Services › Real Estate Investment Trusts
Price History
Feb 9, 2026 — May 15, 2026Investment Snapshot
- Trading 64% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 6.1% — below-average profitability
- Revenue growing at 10% annually
Sabra Health Care REIT, Inc. - Common Stock (SBRA) is a Financial Services company operating in Real Estate Investment Trusts, listed on the NASDAQ , with a market capitalisation of $5.3 billion . Key value metrics: P/E ratio 31.6, P/B ratio 1.92, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Sabra Health Care REIT, Inc. - Common Stock — Fundamental Analysis Summary
Sabra Health Care REIT, Inc. - Common Stock (SBRA) is currently trading 64% above its Graham Number of $12.92, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 31.6x.
On financial health, SBRA shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 6.1% (sector average: 4.9%), and manageable leverage with a debt-to-equity ratio of 0.96.
StockPik's composite Value Score for SBRA is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SBRA shows revenue growing at 10% year-over-year, with earnings growing at 23%.
SBRA pays a high dividend yield of 5.7%.